ImageneBio Inc (IMA)

• Market cap: $69.4M
• 1 day: 0.32%
• 5 days: -4.61%
• 1 month: -15.28%
• 3 months: -24.73%
• 6 months: -61.95%
• Year to date: -68.64%
• 1 year: -67.86%
• 5 years: -98.38%
• 10 years: -98.38%
• Sector: Healthcare
• Industry: Biotechnology

About: ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.

Employees: 15